Patents by Inventor Takayoshi Torii

Takayoshi Torii has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11028386
    Abstract: Morpholino oligonucleotides can be produced efficiently in a high yield by a liquid-phase synthesis method, which includes subjecting a reaction mixture of a condensation reaction to an extraction operation and separating the morpholino oligonucleotide as a resultant product to the organic layer side.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: June 8, 2021
    Assignee: AJINOMOTO CO., INC.
    Inventors: Daisuke Takahashi, Takayoshi Torii
  • Publication number: 20200040331
    Abstract: Morpholino oligonucleotides can be produced efficiently in a high yield by a liquid-phase synthesis method, which includes subjecting a reaction mixture of a condensation reaction to an extraction operation and separating the morpholino oligonucleotide as a resultant product to the organic layer side.
    Type: Application
    Filed: September 25, 2019
    Publication date: February 6, 2020
    Applicant: AJINOMOTO CO., INC.
    Inventors: Daisuke TAKAHASHI, Takayoshi TORII
  • Patent number: 10472624
    Abstract: Morpholino oligonucleotides can be produced efficiently in a high yield by a liquid-phase synthesis method, which includes subjecting a reaction mixture of a condensation reaction to an extraction operation and separating the morpholino oligonucleotide as a resultant product to the organic layer side.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: November 12, 2019
    Assignee: AJINOMOTO CO., INC.
    Inventors: Daisuke Takahashi, Takayoshi Torii
  • Patent number: 10415036
    Abstract: Using a morpholino nucleotide wherein 5?-hydroxy group or a hydroxy group present on the substituent of the 5?-hydroxy group is protected by a protecting group having an alkyl group having not less than 10 and not more than 300 carbon atoms and/or an alkenyl group having not less than 10 and not more than 300 carbon atoms as a starting material, a method capable of efficiently producing the morpholino oligonucleotide in a high yield by a liquid phase synthesis can be provided.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: September 17, 2019
    Assignee: AJINOMOTO CO., INC.
    Inventors: Takayoshi Torii, Daisuke Takahashi, Satoshi Katayama
  • Publication number: 20180016580
    Abstract: Using a morpholino nucleotide wherein 5?-hydroxy group or a hydroxy group present on the substituent of the 5?-hydroxy group is protected by a protecting group having an alkyl group having not less than 10 and not more than 300 carbon atoms and/or an alkenyl group having not less than 10 and not more than 300 carbon atoms as a starting material, a method capable of efficiently producing the morpholino oligonucleotide in a high yield by a liquid phase synthesis can be provided.
    Type: Application
    Filed: September 14, 2017
    Publication date: January 18, 2018
    Applicant: AJINOMOTO CO., INC.
    Inventors: Takayoshi TORII, Daisuke Takahashi, Satoshi Katayama
  • Patent number: 9790497
    Abstract: Using a morpholino nucleotide wherein 5?-hydroxy group or a hydroxy group present on the substituent of the 5?-hydroxy group is protected by a protecting group having an alkyl group having not less than 10 and not more than 300 carbon atoms and/or an alkenyl group having not less than 10 and not more than 300 carbon atoms as a starting material, a method capable of efficiently producing the morpholino oligonucleotide in a high yield by a liquid phase synthesis can be provided.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: October 17, 2017
    Assignee: AJINOMOTO CO., INC.
    Inventors: Takayoshi Torii, Daisuke Takahashi, Satoshi Katayama
  • Patent number: 9371353
    Abstract: The present invention provides a protected nucleotide for elongation, which can be purified efficiently and in a high yield by a liquid-liquid extraction operation, and can achieve an oligonucleotide production method by a phosphoramidite method. It has been found that the above-mentioned problem can be solved by a particular oligonucleotide comprising a protected base and/or particular oligonucleotide protected by a branched chain-containing aromatic group at 3?-position.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: June 21, 2016
    Assignee: AJINOMOTO CO., INC.
    Inventors: Kunihiro Hirai, Satoshi Katayama, Takayoshi Torii, Ryotaro Nakaya, Daisuke Takahashi
  • Publication number: 20160076033
    Abstract: Using a morpholino nucleotide wherein 5?-hydroxy group or a hydroxy group present on the substituent of the 5?-hydroxy group is protected by a protecting group having an alkyl group having not less than 10 and not more than 300 carbon atoms and/or an alkenyl group having not less than 10 and not more than 300 carbon atoms as a starting material, a method capable of efficiently producing the morpholino oligonucleotide in a high yield by a liquid phase synthesis can be provided.
    Type: Application
    Filed: November 20, 2015
    Publication date: March 17, 2016
    Applicant: AJINOMOTO CO., INC.
    Inventors: Takayoshi Torii, Daisuke Takahashi, Satoshi Katayama
  • Publication number: 20150080565
    Abstract: The present invention provides a protected nucleotide for elongation, which can be purified efficiently and in a high yield by a liquid-liquid extraction operation, and can achieve an oligonucleotide production method by a phosphoramidite method. It has been found that the above-mentioned problem can be solved by a particular oligonucleotide comprising a protected base and/or particular oligonucleotide protected by a branched chain-containing aromatic group at 3?-position.
    Type: Application
    Filed: September 19, 2014
    Publication date: March 19, 2015
    Applicant: Ajinomoto Co., Inc.
    Inventors: Kunihiro HIRAI, Satoshi Katayama, Takayoshi Torii, Ryotaro Nakaya, Daisuke Takahashi
  • Patent number: 8846885
    Abstract: The present invention provides a protected nucleotide for elongation, which can be purified efficiently and in a high yield by a liquid-liquid extraction operation, and can achieve an oligonucleotide production method by a phosphoramidite method. It has been found that the above-mentioned problem can be solved by a particular oligonucleotide comprising a protected base and/or particular oligonucleotide protected by a branched chain-containing aromatic group at 3?-position.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: September 30, 2014
    Assignee: Ajinomoto Co., Inc.
    Inventors: Kunihiro Hirai, Satoshi Katayama, Takayoshi Torii, Ryotaro Nakaya, Daisuke Takahashi
  • Publication number: 20130267697
    Abstract: The present invention provides a protected nucleotide for elongation, which can be purified efficiently and in a high yield by a liquid-liquid extraction operation, and can achieve an oligonucleotide production method by a phosphoramidite method. It has been found that the above-mentioned problem can be solved by a particular oligonucleotide comprising a protected base and/or particular oligonucleotide protected by a branched chain-containing aromatic group at 3?-position.
    Type: Application
    Filed: February 15, 2013
    Publication date: October 10, 2013
    Inventors: Kunihiro Hirai, Satoshi Katayama, Takayoshi Torii, Ryotaro Nakaya, Daisuke Takahashi
  • Patent number: 8288526
    Abstract: The present invention provides a method for producing an inosine derivative represented by the following general formula (1) including the steps of subjecting an inosine derivative of general formula (3) to dithiocarbonylation and carrying out radical reduction of the obtained compound. According to the present invention there can be produced compounds useful as anti-AIDS drugs on industrial scale. wherein R1 may be the same or different and are each benzyl group, benzhydryl group or trityl group, each of which may have a substituent in general formulas (1) and (3).
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: October 16, 2012
    Assignee: Ajinomoto Co., Inc.
    Inventors: Takayoshi Torii, Kunisuke Izawa, Doo Ok Jang, Dae Hyan Cho
  • Patent number: 8252920
    Abstract: The present invention provides a method for producing an inosine derivative represented by the following general formula (1) including the steps of subjecting an inosine derivative of general formula (3) to dithiocarbonylation and carrying out radical reduction of the obtained compound. According to the present invention there can be produced compounds useful as anti-AIDS drugs on industrial scale. wherein R1 may be the same or different and are each benzyl group, benzhydryl group or trityl group, each of which may have a substituent in general formulas (1) and (3).
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: August 28, 2012
    Assignee: Ajinomoto Co., Inc.
    Inventors: Takayoshi Torii, Kunisuke Izawa, Doo Ok Jang, Dae Hyan Cho
  • Publication number: 20110028706
    Abstract: The present invention provides a method for producing an inosine derivative represented by the following general formula (1) including the steps of subjecting an inosine derivative of general formula (3) to dithiocarbonylation and carrying out radical reduction of the obtained compound. According to the present invention there can be produced compounds useful as anti-AIDS drugs on industrial scale. wherein R1 may be the same or different and are each benzyl group, benzhydryl group or trityl group, each of which may have a substituent in general formulas (1) and (3).
    Type: Application
    Filed: July 30, 2010
    Publication date: February 3, 2011
    Applicant: Ajinomoto Co., Inc.
    Inventors: Takayoshi TORII, Kunisuke Izawa, Doo Ok Jang, Dae Hyan Cho
  • Patent number: 7816513
    Abstract: The present invention provides a method for producing an inosine derivative represented by the following general formula (1) including the steps of subjecting an inosine derivative of general formula (3) to dithiocarbonylation and carrying out radical reduction of the obtained compound. According to the present invention there can be produced compounds useful as anti-AIDS drugs on industrial scale. wherein R1 may be the same or different and are each benzyl group, benzhydryl group or trityl group, each of which may have a substituent in general formulas (1) and (3).
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: October 19, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Takayoshi Torii, Kunisuke Izawa, Doo Ok Jang, Dae Hyan Cho
  • Publication number: 20090028657
    Abstract: The purpose of the present invention is to propose a machine tool having a linear guide device with new construction enabling exchange of a linear guide by easy work. With regard to a machine tool having linear guide devices 1 each of which has a base 11, guide rails 12 mounted on the base 11, linear guides 2 movably mounted on the guide rails 12, and jack-up mechanism comprising a saddle 9 (moving body) movably supported by the guide rails 12 through the linear guides and jack-up bolts 5 arranged between the base 11 and the saddle, the linear guides are fixed to the saddle through a fixing member, the fixation of the linear guides to the saddle is released by operating the fixing member, and gaps 8 are formed between the saddle and the linear guides by the jack-up mechanism arranged between the base and the saddle (moving body), whereby the linear guides can be exchanged.
    Type: Application
    Filed: December 8, 2005
    Publication date: January 29, 2009
    Inventors: Shunichi Ishikawa, Masato Sugita, Kenji Matsushita, Takayoshi Torii, Koichi Sakal, Jiro Inoue, Tsutomu Sugihara
  • Publication number: 20070179290
    Abstract: Purine nucleosides which are fluorinated at the 3?-position (preferably the ?-position), may be economically and efficiently produced by fluorinating a novel purine nucleoside derivative (1) in which the hydroxyl group at the 5?-position is protected to obtain a novel purine nucleoside derivative (2) in a high yield. The derivative (2) is subjected to desulfurization, deprotection of R1 and, as necessary protection, deprotection, or modification of nucleic acid base moiety, to obtain the desired purine nucleoside (3). wherein each symbol is as defined in the specification.
    Type: Application
    Filed: January 30, 2006
    Publication date: August 2, 2007
    Applicant: AJINOMOTO CO. INC.
    Inventors: Takayoshi Torii, Tomoyuki Onishi, Kunisuke Izawa
  • Publication number: 20060229275
    Abstract: 2-Deoxy-L-ribofuranosyl chloride compounds may be produced on an industrial scale by dehalogenating a 2-deoxy-2-halo-L-arabinofuranose compound to give a 2-deoxy-L-ribofuranose compound, and then reacting this compound with a chlorinating agent.
    Type: Application
    Filed: March 22, 2006
    Publication date: October 12, 2006
    Applicant: AJINOMOTO CO. INC
    Inventors: Toshihiro Nishikawa, Takayoshi Torii, Tomoyuki Onishi
  • Publication number: 20060094870
    Abstract: The present invention provides a method for producing an inosine derivative represented by the following general formula (1) including the steps of subjecting an inosine derivative of general formula (3) to dithiocarbonylation and carrying out radical reduction of the obtained compound. According to the present invention there can be produced compounds useful as anti-AIDS drugs on industrial scale. wherein R1 may be the same or different and are each benzyl group, benzhydryl group or trityl group, each of which may have a substituent in general formulas (1) and (3).
    Type: Application
    Filed: December 16, 2005
    Publication date: May 4, 2006
    Applicant: Ajinomoto Co., Inc.
    Inventors: Takayoshi Torii, Kunisuke Izawa, Doo Jang, Dae Cho
  • Publication number: 20050171126
    Abstract: 2?,3?-didehydro-2?,3?-dideoxypurine nucleoside compounds and 2?,3?-dideoxypurine nucleoside compounds may be produced efficiently by treating a 3?-deoxy-3?-bromopurine nucleoside compound with a perfluoroalkanesulfonyl fluoride in the presence of a base to give a 2?,3?-didehydro-2?,3?-dideoxypurine nucleoside compound, which may be converted to a 2?,3?-dideoxypurine nucleoside compound, by catalytic hydrogenation.
    Type: Application
    Filed: December 21, 2004
    Publication date: August 4, 2005
    Applicant: Ajinomoto Co., Inc.
    Inventors: Takayoshi Torii, Tomoyuki Onishi, Kunisuke Izawa